Home
    Abstracts
    Registration
    Accommodation
    Keep me Updated
     Home
     Welcome Note
     Committees
     Faculty
     Timetable
     Scientific Program
     Poster Presentations
         Poster Presentation Guidelines
     Abstract Submission
     Best Abstract Competition
     Travel Grants
     Registration
     Accommodation
     Accompanying Persons Program
     Sponsorship & Exhibition
     Sponsors
     General Information
     Invitation Letter
     About Athens
     Continuing Medical Education/CME
     Italian agent for Italian companies
     Past & Future CONy Congresses
     Links
     Contact Us
Controversies in Neurology (CONy)
Hilton Hotel, Athens, Greece, October 23-26, 2008
 
  Poster Presentations
   
Posters will be presented in 2 groups:
   Group A: Friday, October 24, 2008
   Group B: Saturday, October 25, 2008
 
Posters are sorted by topic and are in alphabetical order according to the presenting author.
Posters should be mounted on the morning of the allocated day and dismantled at the end of that day's sessions.
The Organizing Committee will not be responsible for posters that are not removed on time.
  
 
List of Poster Boards
  

Group A
Friday, October 24, 2008
 
# Headache
1 PROPHYLACTIC TREATMENT OF MIGRAINE- HERBS  AND LIFESTYLE CHANGES OR DRUGS?
K. Blazina, J. Franjic, D. Petravic, B. Ribaric, D. Mahovic-Lakusic
Croatia
  
2 TRIGGER FACTORS IN CHILDHOOD HEADACHE
G. Dizdarer, N. Cetin, M. Y‎ld‎r‎mer, Z. Sahbudak, A. Kaya, N. Aksu
Turkey
 
3 BIOLOGICAL STRESS MARKERS IN MIGRAINE PATIENTS WITH HEAVY STRESS BURDEN
K.E. Hedborg, C.B. Muhr
Sweden 
 
4 ANTICEPHALGIC PHOTOPROTECTIVE PREMEDICATED MASK: A REPORT OF A SUCCESSFUL STUDY OF A TREATMENT FOR MIGRAINE AND/OR TENSION HEADACHES
M.I. Hyson
USA
  
5 A RARE CAUSE OF HEADACHE
S.Y. Lee, D.K. Skree, J. Thomas
Singapore
  
6 HEADACHE IN LOCAL WAR PARTICIPANTS: SPECIFIC FEATURES
E.V. Mikhaylova, A.P. Ratchin, K.A. Yakunin
Russia 
  
7 ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL)
E. Okuyucu, O. Guven, T. Duman, E. Ucar, I.M. Melek, E. Akcin
Turkey
 
8
CLOSURE OF ATRIAL SEPTAL DEFECTS: A NEW TREATMENT FOR MIGRAINE?
R.A. Providencia, C.S. Silva, A. Leitao, A. Quaresma, M.H. Ramos, F. Pissara, M.F. Silva, M. Costa, N. Quintal,
I. Luzeiro, A.M. Leitao-Marques
Portugal
    
Neurodegenerative Diseases
9 PRESYMPTOMATIC SPONDYLOTIC CERVICAL MYELOPATHY - AN UPDATED PREDICTIVE MODEL
J. Bednarik, Z. Kadanka, M. Kerkovsky, L. Dusek, S. Vohanka, O. Novotny, I. Urbanek
Czech Republic 
 
10
MEGALIN PROMOTER POLYMORPHISM ASSOCIATED WITH INCREASED ALZHEIMER´S DISEASE RISK
E. Carro, V. Teo, M. Bullido, A. Martinez-Garcia, D. Antequera, J. Clarimon, I. Ferrer, T. Gomez-Isla, F. Bermejo, F. Valdivieso
Spain
  
11
TRANSMISSION OF ALZHEIMER DISEASE
L.D. Estrada, R.F. Morales, C.A. Soto
USA
  
12
NSAID USE AND THE RISK OF PARKINSON'S DISEASE: A META-ANALYSIS OF OBSERVATIONAL STUDIES
M.M. Etminan, M. Wiens, S. Jafari, A. Etminan
Canada
  
13
DECREASE IN SEVERE HYPERHYDROSIS WITH WEIGHT LOSS -- WHAT IS THE MECHANISM FOR HYPERHYDROSIS IN PARKINSON'S DISEASE?
L.J. Jaffe
USA
  
14
DEPRESSIVE SYMPTOMS IN ALZHEIMER’S DISEASE AND VASCULAR DEMENTIA PATIENTS: CONTROVERSIAL SUBJECT
V.A. Kholin, K.N. Polyeteyeva, N. Bachinskaya
Ukraine
 
15
ARE DOPAMINERGIC NEURONS IN SUBSTANTIA NIGRA DAMAGED IN PATIENTS WITH RESTLESS LEGS SYNDROME?
J.M. Kim
Korea
  
16
HEMIPARKINSONISM - CASE REPORT
S.I. Kostic, T.B. Smiljkovic, J.D. Potic, V.D.J. Dedic, D. Vranjes
Serbia
 
17
MER IS CRITICAL IN STN DBS SURGERY
M. Kurtis, W. Smith, Q. Yu, R. Goodman, G.M. McKhann, L.M. Winfield, B. Ford, S.L. Pullman
Spain
  
18
ASSOCIATION OF DEVELOPING PATHOLOGICAL GAMBLING AND DOPAMINE AGONIST THERAPY IN PARKINSON'S DISEASED PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF STUDIES PERFORMED IN CLINICAL SETTINGS
M. Nashid
USA
 
19
MOLECULAR MARKERS OF PARKINSON’S DISEASE: LRRK2 MUTATIONS AND ALPHA-SYNUCLEIN LEVEL
S.N. Pchelina, A.K. Emelyanov, O.N. Ivanova, A.F. Yakimovskii, A.L. Schwarzman
Russia
 
20
IDENTIFICATION OF MILD COGNITIVE IMPAIRMENT SUBTYPES IN A SPANISH COHORT. A TWO YEARS FOLLOW-UP
H.R. Peraita, J.L. Dobato, C.Diaz
Spain
 
21
HOMOCYSTEINEMIA, LEVODOPA DOSE AND DISEASE STAGING IN PARKINSON'S DISEASE PATIENTS
L.C. Perju-Dumbrava, S.P. Pasca, M. Dronca, L.M. Muntean, L.D. Perju-Dumbrava
Romania
 
22
PREDICTIVE DIAGNOSTIC TESTING OF VON HIPPEL-LINDAU DISEASE: FIVE YEAR FOLLOW-UP
A.O. Rasmussen, A. Ochoa, I. De Biase, P. Yescas, A.L. Sosa, Y. Rodriguez, M. Chavez, M. Lopez, E. Alonso, S.I. Bidichandani
USA
 
23
GRAY MATTER VOLUME INCREASE IN PATIENTS WITH FRIEDREICH ATAXIA (FRDA) AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN (RHUEPO): A VOXEL-BASED MORPHOMETRY (VBM) STUDY
W.M. Santner, K. Egger, M.F. Schocke, S. Hering, B. Sturm, B. Scheiber-Mojdehkar, W. Jaschke, S. Bosch
Austria
  
24
Severe impairment battery: Experience from the memory clinic in Thailand
V. Senanarong, A. Ruksathaput, N. Aoonkaew, N. Poungwarin, S. Udompunthurak, R.S. Doody
Thailand
  
25
INDIVIDUALIZED, COMPUTER-ASSISTED COGNITIVE TRAINING IMPROVES MEMORY IN MS: A FINE-GRAINED ANALYSIS OF RAW DATA
E. Shatil, A. Melzer, O. Horvitz, A. Miller
Israel
 
26
HANDEDNESS DOES NOT PREDICT ASYMMETRY OF MOTOR SYMPTOMS OF PARKINSON'S DISEASE
J. Stochl, H. Brozova, E. Ruzicka, K.A. Hagtvet
Czech Republic
 
27
TREATMENT OF PSYCHOTIC DISORDERS IN PARKINSON DISEASE
A.G. Tiugan, C.T. Radut
Romania
 
28
COGNITIVE EVALUATION OF PATIENTS WITH SPINOCEREBELLAR ATAXIA TYPE 1
C.P. Trevisan, F. Cappa, S. Lombardi, G. Camporese, E. Pastorello
Italy 
 
29
CLINICAL DIAGNOSIS OF SPORADIC CREUTZFELDT-JAKOB DISEASE: A CASE REPORT AND REVIEW OF LITERATURES
G.Q. Wang, W.W. Zhang, W.M. Yin
China
 
30
PREVALENCE OF NEUROPSYCHIATRIC SYMPTOMS IN THE COMMUNITY DWELLING ELDERLY SUBJECTS WITH ALZHEIMER’S DISEASE
J.C. Youn, D.Y. Lee, I.H. Choo, J.H. Jhoo, K.W. Kim, J.I. Woo
Korea
 
# Stroke
31 MRI CLASSIFICATION OF 647 CASES OF ACUTE CEREBRAL INFARCTION FROM 6 HOSPITALS IN BEIJING
Y.H. Huang, W.W. Zhang, L. Lin, W. Wei, Y. Li, X.X. Zhao
China
 
32 ANGIOGENIC BLOOD-BRAIN BARRIER DAMAGE IN CHRONIC HYPOPERFUSION: AN IMPORTANT FACTOR FOR ISCHEMIC DEMYELINATION?
L. Lin, W.W. Zhang, Y.H. Huang, W.H. Guo, X.X. Zhao
China
 
33
THE COMPARISON OF THE INCIDENCE AND THE KNOWLEDGE ABOUT STROKE IN YONG STROKE BETWEEN BEIJING AND OUT OF BEIJING
X.X. Zhao, Y.H. Huang, W.W. Zhang
China
 
34
DOES THE METHOD OF MICROCATHETER INTRA-ARTERIAL TPA DELIVERY AFFECT REPERFUSION RATE?
G.A. Christoforidis, Y. Mohammad, M. Kontzialis, A.P. Slivka
USA
 
35
CAROTID ARTERY FIBROMUSCULAR DYSPLASIA. A CASE REPORT
A.C. Cinova, P.H. Hlustik, R.O. Obereignerù, K.K. Kollarova, P.K. Kanovsky
Czech Republic
 
36
RECOVERY FROM RIGHT HEMISPHERE ISCHEMIC STROKE IN PATIENTS WITH VISUOSPATIAL NEGLECT VS. PATIENTS WITHOUT VISUOSPATIAL NEGLECT
S.M. Deme, C.D. Jianu, P.D. Nanu, S. Kory-Calomfirescu, D.S. Ioncu
Romania
 
37
CORRELATION BETWEEN UNILATERAL SUBOCLUSION OF INTERNAL CAROTID ARTERY AND CLINICAL FINDINGS AND COMPUTED TOMOGRAPHY FINDINGS
T.S. Ducic, N.J. Ivanovic, M.M. Vukicevic, T. Stricevic, B. Georgievski Brkic, M. Savic
Serbia
 
38
SHOULD CLOPIDOGREL BE ADDED ON TOP OF ASPIRIN BEFORE CAROTID STENTING OF HIGH RISK PATIENTS?
W.C. Fong, K.M. Cheng, Y.L. Cheung, K.W. Tang
Hong Kong
 
39
AUTOEXPANDABLE STENTS IN THE MANAGEMENT OF INTRACRANIAL ANEURYSMS
A. Garcia De La Fuente
Mexico
 
40
POLYMORFISM A2 IN PLATELET GLYCOPROTEIN IIb/IIIa FACTORS IN PATIENTS WITH ISCHEMIC STROKE
M. Ivanov, S.P. Gecheva, , P. Ivanov, R. Komsa-Penkova, T. Lukanov, B. Stamenov, I. Ivanov
Bulgaria
 
41
LONGITUDINAL DYNAMICS OF CEREBROVASCULAR DISEASES MORTALITY IN ARMENIA (1980-2007)
L.G. Gimoyan, A.V. Kazaryan, S.H. Gayane
Armenia
 
42
ASSESSMENT OF NEUROIMAGING IN THE DIAGNOSIS OF CEREBRAL VENOUS THROMBOSIS
M. jacoby, L. george, E.P. Finnerty
USA
 
43
A STANDARDIZATION STUDY OF THE CZECH VERSION OF THE MISSISSIPPI APHASIA SCREENING TEST IN STROKE PATIENTS
M. Kostalova, J. Bednarik, E. Bartkova, K. Sajgalikova, A. Dolenska, L. Dusek
Czech Republic
 
44
EVOLUTION OF APHASIA PROFILE IN PATIENTS WITH WERNICKE’S APHASIA
M.S. Kwon, H.S. Sim, J.H. Lee, D.L. Na, K.H. Lee
South Korea
 
45
ISCHEMIC STROKE IN YOUNG: REVERSIBLE RISK FACTORS WITH UNCLEAR ETIOLOGY
V. Mehrotra, D. Goel
India
 
46
CEREBROVASCULAR  SEQUELAE OF  PREGNANTS TOXAEMIA: GLANCE AT OLD UNSETTLED PROBLEM
I.V. Verulashvili
Georgia
 
# Various Topics
47
DETECTING MALINGERING IN PATIENTS COMPLAINING FOR NEUROLOGICAL AND NEUROPSYCHOLOGICAL SYMPTOMS
M. Constantinou
Cyprus
 
48
ISOLATED NEUROSARCOIDOSIS: NOT MERELY A DIAGNOSIS OF EXCLUSION !
M. Curone, L.M. Leone, V. Tullo, A. Proietti Cecchini, G. Bussone
Italy
 
49
SURPIRSES IN A CASE OF NEUROFIBROMATOSIS TYPE I IN AN ADULT
C.St. Filos, A.C.L. Rotar, I. Radu, C.D. Popescu, O. Arhire, M. Grigoras, I. Petcu, M. Grigorovici
Romania
 
50
THE ROLE OF NEUROBIOLOGY IN SEXUAL ORIENTATION - THE GAY BRAIN
J. Goldstein
USA
 
51
INVERSION EFFECT OF CHINESE CHARACTERS
J.J. Gong, W.W. Zhang, Y. Zhang, J. Li
China
 
52
ATYPICAL EEG RHYTHM CORRESPONDING TO READING ACTIVITY: ABOUT THE STUDY OF ONE CASE
A. Guen, C.T. Moret Chalmin
France
 
53 ALTERATIONS OF THE HUMAN VISUAL CORTEX DURING NORMAL AGING AND ALZHEIMER’S DISEASE REVEALED BY SILVER STRAINING METHODS
I. Mavroudis, K. Tsamis, D. Mytilinaios, D.F. Fotio, S.N. Njau, V. Costa, S.J. Baloyannis
Greece
 
54
 
 
 
55
 
 
 
 
56
 
ANTI-GM1 ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
E. Koutsouraki, A. Hatzifilippou, C. Cosetsidou, E. Avdelidi, T. Banaki, V.G. Costa, S.J. Baloyannis
Greece
 
 
CO MORBIDITY IN ALZHEIMER’S DISEASE. DIFFERENCES ACCORDING TO THE   STAGE, THE AGE, THE GENDER AND OTHER DEMOGRAPHICAL PARAMETERS.
Tsolaki Magda1, Mauredaki Penelope1, Mourgela Anna1, Patrizia Mecocci2, Hilka Soininen3, Bruno Vellas4 , Iwona Kloszewska5, Simon Lovestone6 on behaulf of the Addneuromed consortium
 

PRESERVATION OF LATENCIES-AMPLITUDES OF ALL AUDITORY EVENT RELATED POTENTIALS IN PATIENTS WITH MCI AFTER LONGITUDINAL COGNITIVE STIMULATION

Tsolaki M., Kounti F., Papaliagkas V., Kimiskidis V., Vlaikidis N., Anogiannakis G

Group B
Saturday, October 25, 2008
 
# Epilepsy
1 MILD GENERALIZED EPILEPSY AND PAROXYSMAL EXERCISE INDUCED DYSTONIA DUE TO GLUT1 DEFICIENCY
Z. Afawi, A. Suls, D. Ekstein, S. Kivity, A.D. Korczyn, F. Berkovic
Israel
  
2 IS TEMPERATURE REGULATION DIFFERENT IN CHILDREN SUSCEPTIBLE TO FEBRILE SEIZURES?
J.M. Dooley, K.E. Gordon, E.P. Wood, P. Bethune
Canada
 
3 SPECIES-SPECIFIC ACTIONS OF VALPROIC ACID ON MICROGLIA
M.G. Dragunow
New Zealand
 
4 THE ROLE OF PROVOCATIVE TEST FOR THE DIAGNOSE OF PSYCHOGENIC NONEPILEPTIC SEIZURES IN A CASE OF OBSTETRIC EMERGENCY
H. Foreid, C. Bentes, J. Cortez Pimentel
Portugal
 
5
LEVETIRACETAM MONOTHERAPY IN INDIAN PATIENTS WITH EPILEPSY
A. Kumar
India 
 
6 EPILEPSY IN PREGNANCY
Si. Nazarpour, So. Nazarpour, M. Behnam moradi, M. Robatjazi
Iran
 
7 STATUS EPILEPTICUS INDUCED BY ANOXIA IN A CHILD WITH BREATH HOLDING SPELLS
K. Pienczk-Reclawowicz, E. Pilarska, M. Lemka
Poland
 
8 PSYCHOLOGIC DISORDERS IN EPILEPTIC PATIENTS IN IRAN 2005
F. Sahbaei Roy, S. Molla Hosaini, M. Mahmodi, Z. Parsaniya
Iran
 
9
STATUS EPILEPTICUS CONTROLLED WITH INTRAVENOUS IMMUNOGLOBULIN: A CASE REPORT
H.Y. Shyu
Taiwan R.O.C
  
# Experimental
10 PROTECTIVE EFFECT OF THE HYPOTHALAMIC PROLIN RICH PEPTID ON THE NEURONS OF SUPERIOR VESTUBULAR NUCLEUS LABYRINTHECTOMIZED RATS
A.A. Galoyan, S.M. Minassian, S.H. Sarkisyan, V.A. Chavushyan, I.B. Meliketyan, M.L. Yeghiazaryan, J.B. Sarkissian
Armenia
 
11 EFFECT OF BAIMAI OINTMENT ON THE EXPRESSION OF PROTEIN P38MAPK AND GAP-43 IN ISCHEMIC BRAIN OF RATS
W.H. Guo, W.W. Zhang, Y. Li, Y.H. Huang
China
 
12 EFFECTS OF OCTYL GALLATE ON GLUTAMATE-INDUCED [CA2+]I INCREASE IN CULTURED RAT HIPPOCAMPAL NEURONS
Y.J. Hong, S.J. Hahn, S.H. Yoon
Korea
 
13 P2Y PURINOCEPTOR-ERK SIGNALING INVOLVED IN THE PRECONDITIONING-INDUCED ISCHEMIC TOLERANCE OF ASTROCYTES IN CULTURE
S.S. Iwabuchi, K. Kawahara
Japan 
 
14 ISCHEMIA-INDUCED CHANGES IN EXPRESSION PATTERN OF CALCIUM BINDING PROTEINS CALBINDIN D28K, PARVALBUMIN AND CALRETININ, IN THE RAT RETINA
I.B. Kim, J. Cha, J. Jeon, S.A. Kim, M.H. Chun
South Korea
 
15
BAK AND BAX EXPRESSION IN STREPTOZOTOCIN MODEL OF ALZHEIMER’S DISEASE
Z. Kundurovic, S. Hasanagic, F. Gavrankapetanovic, N. Bilalovic, M. Salkovic-Petrisic, P. Riederer
Bosnia and Herzegovina
 
16 PROTECTIVE EFFECTS OF AMPICILLIN ON DELAYED HIPPOCAMPAL NEURONAL DEATH INDUCED BY TRANSIENT GLOBAL FOREBRAIN ISCHEMIA IN MICE
K.E. Lee, K.O. Cho, S.K. Kim, K.H. Jeong, S.Y. Kim
Korea 
 
17 DO REACTIVE OXYGEN SPECIES SCAVENGERS HAVE THE ANTINOCICEPTIVE EFFECT THROUGH SPINAL MECHANISM IN FORMALIN RAT?
L.W.H. Lee, Y.K. Ko
South Korea
 
18 UPREGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C AND ITS RECEPTOR IN THE RAT HIPPOCAMPUS FOLLOWING TRANSIENT FOREBRAIN ISCHEMIA
M.Y. Lee, Y.J. Shin, J.S. Choi, J.Y. Lee, J.H. Cha, J.Y. Choi, M.H. Chun
South Korea
  
19 SERUM ADIPONECTIN IN ACUTE ISCHEMIC STROKE
S. Marousi, G. Theodorou, M. Karakantza, J. Ellul, P. Papathanasopoulos
Greece
  
20 EFFECT OF AMYLOID PEPTIDE AND ACETYLCHOLINESTERASE INHIBITOR ON PBMC CULTURES
M. Reale, V. Bellante, D. Gambi, C. Iarlori
Italy
  
21 TETRAHYDROBIOPTERIN, NITRIC OXIDE SYNTHASE AND FDG MICROPET IN HYPOXIC ISCHEMIA IN NEONATAL PIGS
H. Shintaku, H. Fujioka, S. Nozaki, Y. Wada, Y. Watanabe, T. Sakaguchi, E. Yamaguchi, T. Yokoi, T. Yamano
Japan
 
22 MGLUR5-RELATED SIGNAL TRANSDUCTION PATHWAYS IN HIPPOCAMPAL CA1 PYRAMIDAL NEURONS IN PILOCARPINE MODEL OF STATUS EPILEPTICUS IN MGLUR5+/+ MICE
F.R. Tang, J.X. Liu, Y.C. Tang, Y. Liu
Singapore
 
23
EXPERIMENTAL STUDY OF ƒÀ-SODIUM AESCINATE IN RATS WITH FOCAL CEREBRAL ISCHEMIA / REPERFUSION
W. Wei,  W.W. Zhang
China
   
# Myasthenia Gravis
24
AN UNUSUAL CASE OF MYASTHENIA GRAVIS
F.I. Trifan, D.P. Bicu, F.M. Tapu, M.C. Tapu
Romania
  
# Multiple Sclerosis
25 MESENCHYMAL STEM CELLS EFFECT IN SEVERE NEUROMYELITIS OPTICA
A.O. Dulamea, M.P. Sirbu Boeti, S. Dulamea, M. Chivu, C. Bleotu, C. Efrimescu, A. Campeanu, I. Popescu
Romania
 
26 MULTIPLE SCLEROSIS OR ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)? A DIAGNOSTIC DILEMMA OF AN ACUTE EPISODE IN CHILDHOOD
G. Georgoulis, N. Loli, K. Skiadas, A. Covanis
Greece
 
27 CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE IN MULTIPLE SCLEROSIS: A PILOT STUDY IN A SPANISH POPULATION
L. Guerrero, A. Garrote, D. Perez, A. Mendoza, T. Lopez-Alburquerque, C. Moran, A.B. Guerrero, D. Bernardo, A.B. Caminero, J. Martin-Polo, H. Alonso, E. Arranz
Spain
 
28 VITAMIN D LEVELS IN PATIENTS WITH MULTIPLE SCLEROSIS
A. Kutlu, C. Ozerdem, H. Efendi
Turkey 
 
29 DOES COINHERITANCE OF MULTIPLE SCLEROSIS AND PARKINSONISM REFLECT A COMMON PATHOGENETIC MECHANISM?
K. Markopoulou, M. Filipi, Z.K. Wszolek, A. Papadimitriou, B.A. Chase
Greece
 
30 AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) AS A TREATMENT MODALITY FOR MULTIPLE SCLEROSIS (MS): A 9-YEAR EXPERIENCE OF THE RUSSIAN COOPERATIVE GROUP FOR CELLULAR THERAPY
Y.L. Shevchenko, A.A. Novik, A.N. Kuznetsov, B.V. Afanasiev, I.A. Lisukov, O.A. Rykavicin, A.A. Myasnikov, V.Y. Melnichenko, D.A. Fedorenko, R.V. Kruglina, A.V. Kartashov, G.J. Gorodokin
Russia
 
31 THE VALUE OF  INTRATHECAL MRZ REACTION  AND OLIGOCLONAL IGG BANDS FOR DISCRIMINATION BETWEEN PRIMARY PROGRESSIVE AND RELAPSING-REMITTING COURSE OF MULTIPLE SCLEROSIS
P. Stourac, J. Bednarova, M. Hladikova, P. Praksova, Y. Benesova
Czech Republic
 
32 METHIONINE ENKEPHALIN PREVENTS AND REVERSES CLINICAL DISEASE OF EAE IN MICE: IMPLICATIONS FOR A BIOLOGIC APPROACH TO TREATING MULTIPLE SCLEROSIS
G.A. Thomas, A. Rahn, J. McLaughlin, A.P. Turel
USA
 
33 LOW-DOSE NALTREXONE (LDN) REDUCES INFLAMMATORY RESPONSE AND DEMYELINATION, AND ATTENUATES BEHAVIORAL SCORES, IN MOG-INDUCED EAE
A.P. Turel, K.A. Rahn, P.J. McLaughlin, G.A. Thomas
USA
 
34
DYSREGULATED PRODUCTION OF IL-12 AND IL-23 IN RR-MS PATIENTS.
G. Vianale, A. D'Intino, V. Bellante, G. Mincione, D. Gambi, R. Muraro
Italy
   
# Stroke
35 WHICH ARM MOTION THERAPEUTIC EXERCISES TO CHOOSE TO IMPROVE THE HEMIPLEGIC SHOULDER 3D KINEMATICS?
A.C. Inacio, A.S. Sequeira, S. Pinto, A.G. Pascoal
Portugal
 
36 THREE DIFFERENT TYPES OF POSITIONING HEMIPLEGIC SHOULDER: ARE THERE SOME CHANGES?
S. Pinto, A. Sequeira, A.C. Inacio, A.G. Pascoal
Portugal
 
37
CLOSE KINETIC CHAIN EXERCISES IN HEMIPLEGIC UPPER LIMB. SHARED OR UNILATERAL WEIGHT BEARING?
A. Sequeira, A.C. Inacio, S. Pinto, A.G. Pascoal
Portugal
   
#  Various Topics
38 DISSOCIATIVE DISORDERS IN NEUROLOGY
K.K. Kollarova, R.O. Obereigneru, A.C. Cinov, P.K. Kanovsky
Czech Republic
 
39 CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY ASSOCIATED WITH SOLITARY PLASMACYTOMA
Y. Krikmann, S. Reim, S. Schneider
Estonia
 
40 RHEUMATOID MENINGITIS AS A RARE EXTRA-ARTICULAR MANIFESTATION OF RHEUMATOID ARTHRITIS
F. Luessi, J. Knabe, V. Bernedo, H. Muller, P. Stoeter, T. Vogt, F. Thomke
Germany
 
41 CONTROVERSY IN THE TREATMENT WITH REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) IN THE CENTRAL NERVOUS DISEASES (CNS)
J.H. Mally
Hungary
 
42 CLINICAL EVALUATION OF AUTONOMIC FUNCTION IN PATIENTS WITH GUILLAIN-BARRE' SYNDROME
M.A. Mezaal, A.S. Nadeem, A.Y. Al Memar, J. Kimber
UAE
 
43 SYNDROMA  BRAIN STEAM IN A PATIENT WITH MULTIPLE KAVERNOMA
V.R. Miletic, K.R. Savic Vujovic, M. Vukicevic, L. Lelic, B. Georgijevski Brkic, M. Savic, I. Krdzic
Serbia
 
44 CARPAL TUNNEL SYNDROME IN PREGNANCY
So. Nazarpour, Si. Nazarpour, M. Behnam moradi
Iran
 
45 TO BE OR NOT TO BE AN ENCEPHALITIS?
C.R. Nobrega, S. Nunes de Oliveira, R. Almeida
Portugal
 
46 DECREASED LOWER BACK PAIN AFTER NON-INVASIVE SPINAL DECOMPRESSION MAY BE DUE TO RESTORED DISC HEIGHT
J.V. Pergolizzi, C. Apfel, S. Cakmakkaya, W. Martin, F. Florio, C. Richmond
USA
 
47 HERPES SIMPLEX VIRUS 6 INDUCED GUILLAIN-BARRE SYNDROME IN PREGNANT FEMALE
M. Rakusa, M. Menih, V. Savanovic
Slovenia
 
48 UNUSUAL ETIOLOGY  OF RECURRENT REFRACTORY PAROXYSMAL VÉRTIGO. EXPERIENCE WITH 15 CASES
R.A. Rangel Guerra
Mexico
 
49 PILOT: EFFECTIVENESS & SAFETY OF NON-SURGICAL SPINAL DECOMPRESSION
C.A. Richmond, J.V. Pergolizzi, A. Macario, C. Apfel, M. Auster, F. Florio,
J. Leslie
USA
 
50 CARPAL TUNNEL SYNDROME IN PREGNANCY: FOLLOW UP AND TREATMENT
M. Robatjazi
Iran
 
51 COULD WE STOP PAIN WITH HYPNOSIS?
Z. Sadeghi Afjeh
Iran
 
52 A STUDY OF CLINICAL SIGNIFICANCE OF DIZZINESS IN DIAGNOSTIC APPROACH FOR CHILDREN WITH CHRONIC HEADACHE
H.J. Yoo, J.W. Oh, H.S. Lee
South Korea 
 
53 CONTROVERSIES AND CERTAINTIES IN A GROUP OF PATIENTS WITH PARKINSON DISEASE, ON TREATMENT WITH DUODENAL L-DOPA INFUSION
G. Gusmaroli, M. Ravagnani, D. Barbagli, E. Miotello, L. Coppo, K. Perrone, R. Tarletti, E. Barbero, U. Massazza
Italy


Home    Registration     Accommodation     Contact Us   
Copyright © 2007 comtecmed.com. All rights reserved. Created by     WebStudio.co.il